Inclusion criteria |
• Written informed consent |
• Infra-renal AAA with maximum orthogonal diameter of ≥35 mm and ≤49 mm on CTA or ultrasound |
• No current indication for AAA repair, or expectation that this will be revised in 12 months |
• Likely to comply with treatment over 24 months, including seven visits to study centre |
Exclusion criteria |
• Currently taking or likely to start taking an AT1 blocker |
• Currently taking or likely to start taking an ACE inhibitor |
• Previous abdominal aortic surgery |
• Contraindication to telmisartan: |
 o Renal impairment: creatinine >1.5 x ULN |
 o Known renal artery stenosis >70 % of one or both renal arteries |
 o Chronic liver disease (that is, cirrhosis or hepatitis) or abnormal liver function (that is, ALT > 1.5 x ULN) |
 o Electrolyte imbalance |
 o Active gout |